Evidence map›Paper›PMID 39051499›Full record

ArticleJournal of the European Academy of Dermatology and Venereology : JEADV2025

A cross-sectional study on gender differences in body dysmorphic concerns in patients with skin conditions in relation to sociodemographic, clinical and psychological variables.

F Sampogna, T Samela, D Abeni, C Schut, J Kupfer, A P Bewley, A Y Finlay, U Gieler, A R Thompson, T Gracia-Cazaña and 24 more

Abstract readMulticenter Study
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of the European Academy of Dermatology and Venereology : JEADV, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Observational
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

34 authors.

F SampognaClinical Epidemiology Unit, IDI-IRCCS, Rome, Italy.ORCID https://orcid.org/0000-0002-7624-3290
T SamelaClinical Epidemiology Unit, IDI-IRCCS, Rome, Italy.ORCID https://orcid.org/0000-0002-5588-5999
D AbeniClinical Epidemiology Unit, IDI-IRCCS, Rome, Italy.
C SchutInstitute of Medical Psychology, Justus-Liebig-University Gießen, Gießen, Germany.
J KupferInstitute of Medical Psychology, Justus-Liebig-University Gießen, Gießen, Germany.ORCID https://orcid.org/0000-0002-9905-8485
A P BewleyBarts Health NHS Trust & Queen Mary University, London, UK.
A Y FinlayInstitute of Infection and Immunity, School of Medicine, Cardiff University, Cardiff, UK.ORCID https://orcid.org/0000-0003-2143-1646
U GielerDepartment of Dermatology, Justus-Liebig- University Giessen and Vitos Klinik, Giessen, Germany.
A R ThompsonSouth Wales Clinical Psychology Programme, Cardiff & Vale University Health Board, & School of Psychology, Cardiff University, Cardiff, UK.
T Gracia-CazañaMiguel Servet University Hospital, IIS Aragón, Universidad de Zaragoza, Zaragoza, Spain.ORCID https://orcid.org/0000-0002-0523-2076
F BalievaDepartment of Dermatology, Stavanger University Hospital, Stavanger, Norway.
B R FerreiraDepartment of Dermatology, Coimbra University Hospital, Coimbra, Portugal.ORCID https://orcid.org/0000-0002-4808-6398
G B JemecDepartment of Dermatology, Zealand University Hospital, Roskilde, Denmark.
L LienNorwegian National Advisory Unit on Concurrent Substance Abuse and Mental Health Disorders, Innlandet Hospital Trust, Brumunddal, Norway.
L MiseryDepartment of Dermatology, University Hospital of Brest, Brest, France.ORCID https://orcid.org/0000-0001-8088-7059
S E MarronDepartment of Dermatology, University Hospital Miguel Servet, Aragon Psychodermatology Research Group (GAI+PD), Zaragoza, Spain.
S StänderDepartment of Dermatology, University Clinic Münster, Münster, Germany.ORCID https://orcid.org/0000-0003-3612-7786
C ZeidlerDepartment of Dermatology, University Clinic Münster, Münster, Germany.ORCID https://orcid.org/0000-0002-9485-8627
C SzabóInstitute of Psychology, University of Szeged, Szeged, Hungary.
J C SzepietowskiDepartment of Dermatology, Venereology and Allergology, Wroclaw Medical University, Wroclaw, Poland.ORCID https://orcid.org/0000-0003-0766-6342
A ReichDepartment of Dermatology, Institute of Medical Sciences, Medical College of Rzeszow University, Rzeszów, Poland.ORCID https://orcid.org/0000-0002-5573-1754
A SvenssonDepartment of Dermatology and Venereology, Skåne University Hospital, Malmo, Sweden.ORCID https://orcid.org/0000-0002-2821-7418
I K AltunayŞişli Hamidiiye Etfal Research and Training Hospital, Department of Dermatology and Venereology, University of Health Sciences, Istanbul, Turkey.
F J LegatDepartment of Dermatology, Medical University of Graz, Graz, Austria.ORCID https://orcid.org/0000-0002-7785-4739
V Grivcheva-PanovskaSchool of Medicine, PHI University Clinic of Dermatology Skopje, University St Cyril and Methodius, Skopje, North Macedonia.
D V RomanovDepartment of Psychiatry and Psychosomatics, I.M. Sechenov First Moscow State Medical University (Sechenov University), Moscow, Russia.
A N LvovDepartment of Dermatovenereology and Cosmetology, Central State Medical Academy of Department of Presidential Affairs, Moscow, Russia.ORCID https://orcid.org/0000-0002-3875-4030
G TitecaDepartment of Dermatology/Clinique Notre Dame de Grâce, Gosselies, Belgium.ORCID https://orcid.org/0000-0003-3518-9379
N C VulinkDepartment of Psychiatry, Amsterdam UMC, Location Academic Medical Center, University of Amsterdam, Amsterdam, the Netherlands.
L Tomás-AragonesDepartment of Psychology, University of Zaragoza, Zaragoza, Spain.ORCID https://orcid.org/0000-0001-5891-628X
S van BeugenInstitute of Psychology, Health, Medical and Neuropsychology Unit, Leiden University, Leiden, the Netherlands.
A W M EversInstitute of Psychology, Health, Medical and Neuropsychology Unit, Leiden University, Leiden, the Netherlands.
F J DalgardDepartment of Dermatology and Venereology, Skåne University Hospital, Malmo, Sweden.ORCID https://orcid.org/0000-0002-5740-6541
European Society for Dermatology and Psychiatry (ESDaP) Study collaborators

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundDysmorphic concern is an overconcern with an imagined or slight defect in physical appearance that can be a symptom of body dysmorphic disorder (BDD). Appearance-related concerns are frequently reported by people with dermatological conditions. However, relatively little remains known about the relationship between dysmorphic concern and other variables within persons with different skin conditions.

objectivesThe aim of this multicentre, cross-sectional study was to investigate gender differences regarding dysmorphic concern and the prevalence of BDD in a large sample of patients with skin conditions, in relation to sociodemographic, clinical and psychological variables.

methodsParticipants aged ≥18 years with skin conditions were consecutively enrolled in dermatological clinics of 22 European centres. Dysmorphic concern and the possible presence of BDD were measured using the Dysmorphic Concern Questionnaire (DCQ) and compared between men and women in relation to sociodemographic, clinical and psychological variables, and separately for each skin condition.

resultsThe DCQ questionnaire was completed by 5290 dermatological patients. In all categories, mean scores were significantly higher in women than in men. Mean DCQ scores were also higher in women for most skin conditions, with the highest effect size in vitiligo. The percentage of patients who screened positive for BDD on the DCQ was 10.5%, 7.7% of men and 12.7% of women. The prevalence of BDD positive was 6.9% in patients with mild clinical severity, 11.1% for moderate and 19.1% for severe condition. In the multivariate model in patients with mild skin condition, the presence of BDD was positively associated with stress and stigma both in men and in women.

conclusionsDysmorphic concern and BDD were more frequent in women than in men with skin conditions. Both received and actual stigmatization might have an impact on body-related concerns, in particular in women, who may be more at risk for sociocultural reasons.

Indexed as

Body Dysmorphic DisordersBody ImageSkin DiseasesAdolescentAdultAgedCross-Sectional StudiesFemaleHumansMaleMiddle AgedPrevalenceSex FactorsSurveys and QuestionnairesYoung Adult

Identifiers

PMID39051499
PMCPMC11934014

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.